Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes.
Filippo PatruccoElias AllaraMassimo BoffiniMauro RinaldiCristina CostaCarlo AlberaPaolo SolidoroPublished in: Therapeutic advances in chronic disease (2021)
Lung transplant patients treated with everolimus had improvements in renal function and reduced ISD. We observed sustained improvements in lung function for CLAD related to BOS subgroup results, whereas RAS confirmed the 1-year worsening functional trend. Data seem to suggest one more piece of the puzzle in CLAD phenotyping.
Keyphrases
- lung function
- cystic fibrosis
- chronic obstructive pulmonary disease
- air pollution
- high throughput
- electronic health record
- oxidative stress
- big data
- extracorporeal membrane oxygenation
- machine learning
- randomized controlled trial
- kidney transplantation
- wild type
- clinical trial
- drug induced
- phase iii
- artificial intelligence